September 13, 2024 Peter Maag Via email Dear Peter:Separation Agreement • September 16th, 2024 • Kyverna Therapeutics, Inc. • Biological products, (no disgnostic substances)
This letter (the “Agreement”) sets forth the terms and conditions of your separation from Kyverna Therapeutics, Inc. (the “Company”) in connection with your resignation of employment. In order to facilitate a smooth transition of your duties, this Agreement also sets forth the terms of your service as a contractor of the Company for a transition period following your resignation of employment.
